5- 3- (2,5-Dichloro-4,6-dimethyl-1-oxy-pyridin-3-yl) 1,2,4 oxadiazol-5-yl -3-nitrobenzene-1 crystalline forms 2-diol

摘要

This invention relates to novel polymorphs of (HO)2NO2(C6H)(C2N2O)(C5N)(CH3)2Cl2O, to processes for their preparation, and to pharmaceutical compositions containing said novel polymorphs as active pharmaceutical ingredient.